CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.05%)
As of: Oct 21, 2026 · 10:56 AM EDT

CASI Pharmaceuticals (CASIF) Operating Leases (2021 - 2025)

Updated

CASI Pharmaceuticals (CASIF) reported Operating Leases of $1.44 million for Q4 2025, down 43.2% from $2.54 million a year earlier.

Analysis

CASI Pharmaceuticals (CASIF) Operating Leases (2021 - 2025) Analysis & Trends

Dating back to Q4 2021, CASI Pharmaceuticals' Operating Leases record includes 5 quarters.

  • Operating Leases has a four-year compound annual growth rate of 6.9% (FY2021 to FY2025).
  • By year, Operating Leases came in at $2.54 million in FY2024 (+56.9%), $1.62 million in FY2023 (+239.5%), $476,000 in FY2022 (-56.9%) and $1.11 million in FY2021.
  • The Q4 2025 figure ranks as the lowest quarterly Operating Leases since Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CASI Pharmaceuticals 1.86 Mn -18.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.44 Mn
Dec 31, 2024 2.54 Mn
Dec 31, 2023 1.62 Mn
Dec 31, 2022 476,000.00
Dec 31, 2021 1.11 Mn
API Access

CASI Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=CASIF&period=max&api_key=YOUR_API_KEY